Physician profile
Lara E Green
NPI 1558339184
$276.43
in general payments reported to CMS, 2019-2025
9 companies · $178 in 2025
The $178 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $50.63 · 2023: $47.82 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $225.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $62.68 | 2021-2023 | Rybelsus, Ozempic, Wegovy |
| Astellas Pharma US INC | $38.75 | 2025 | Xtandi |
| Immunitybio, INC. | $34.86 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.76 | 2025 | |
| Teleflex LLC | $32.26 | 2025 | Barrigel |
| Merck Sharp & Dohme LLC | $23.82 | 2025 | Keytruda |
| Intuitive Surgical, INC. | $19.92 | 2021 | |
| Redhill Biopharma INC. | $15.85 | 2021 | |
| Sumitomo Pharma America, INC. | $14.53 | 2025 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lara Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.